Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart att… [+3244 chars]
Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes - Medical Xpress
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results fr…
By:The Mount Sinai Hospital
Source:Medical Xpress
Published:
Related News
The 1 Underrated Skill Parents Need To Start Teaching Their Sons - HuffPost
Strategies for parents who want to help their sons cope with feelings of anger in a productive way.
HuffPost
If You Store Your Bread In The Freezer, You're Getting An Unexpected Health Benefit - HuffPost
This can significantly impact your blood sugar management and digestion.
HuffPost
Can This Popular Sleep Supplement Play a Role in Cancer Prevention? - AOL.com
New research suggests magnesium may help lower the risk of colorectal cancer via increasing vitamin D levels in the body. Here's what experts want you to kno...
Women's Health•Korin Miller